GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arqule, Inc. (ARQL) [hlAlert]

Rating:
Buy ARQL
down 77.26 %

Arqule, Inc. (ARQL) rated Buy

Posted on: Friday,  Sep 14, 2007  9:25 AM ET by Lazard Capital

Lazard Capital rated Buy Arqule, Inc. (NASDAQ: ARQL) on 09/14/2007, when the stock price was $7.74. Since
then, Arqule, Inc. has lost 77.26% as of 01/22/2016's recent price of $1.76.
If you would have followed this Lazard Capital's recommendation on ARQL, you would have lost 77.26% of your investment in 3052 days.

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/14/2007 9:25 AM Buy
None
7.74 10.00
as of 8/27/2015
1 Week up  0.57 %
1 Month down  -4.34 %
3 Months down  -2.76 %
1 YTD down  -18.13 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy